Sector News

Fresenius Medical Care names Martin Fischer as CFO

July 23, 2023
Life sciences

Fischer will join Fresenius Medical Care as CFO starting on Oct. 1, the company announced Monday. The Germany-based firm, which makes dialysis products and operates a network of clinics, has shuffled its leadership as parent company Fresenius plans to spin out the unit by the end of the year.

In December, Fresenius Medical Care promoted CFO Helen Giza to CEO. Giza will continue to serve as acting CFO for the company until Fischer starts this fall. When the company becomes a German stock corporation, Fischer will become a member of Fresenius Medical Care’s board.

“Martin Fischer has proven that he can successfully drive fundamental change in organizations. In our organizational transformation and turnaround management, we will benefit from his finance and healthcare expertise,” Giza said in a statement. “Martin will be an important contributor to the execution of our strategy in unlocking value as the leading kidney care company.”

Fischer joins the company after working as head of finance for the Siemens Healthineers Diagnostic Division. Before that, he held other operational and finance positions at Siemens.

He will be based in Bad Homburg, Germany, and will be responsible for Fresenius Medical Care’s global finance.

by Elise Reuter

Source: medtechdive.com

comments closed

Related News

June 22, 2024

Ferring launches online assessment tool, educational platform around male fertility

Life sciences

Because infertility is often branded largely as a women’s issue, many men may be unaware of their own possible role in the matter and may not undergo testing in a timely manner—even though research has shown that men “substantially” contribute to about half of all cases of infertility.

June 22, 2024

Johnson & Johnson blueprints €125M plant upgrade as part of 5-year Italy investment

Life sciences

After plugging nearly 50 million euros into its Italy R&D in the first half of the decade, Johnson & Johnson Innovative Medicine is significantly upping its commitment to the country. Over the next five years, J&J Innovative Medicine, which recently rebranded from Janssen, will plug a projected 580 million euros ($621.7 million) into its Italian business, the company said in a press release.

June 22, 2024

India’s Lupin announces CEO pick for new subsidiary as it moves into the CDMO arena

Life sciences

From vitamin maker to pharmaceutical specialist and now contract manufacturer, India’s Lupin is embarking on a new phase of its corporate journey. Lupin on Monday unveiled its new subsidiary, Lupin Manufacturing Solutions, which is poised to work on the development, production and sale of active pharmaceutical ingredients.

How can we help you?

We're easy to reach